샘플 요청 목록

 카트 문의
시장보고서
상품코드
1782994

세계의 병리학 연구소 시장

Pathology Laboratories
발행일: | 리서치사: Global Industry Analysts, Inc. | 페이지 정보: 영문 377 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

병리학 연구소 세계 시장은 2030년까지 5,648억 달러에 달할 전망

2024년에 3,747억 달러로 추정되는 병리학 연구소 세계 시장은 2024년부터 2030년까지 CAGR 7.1%로 성장하여 2030년에는 5,648억 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 병원 기반 검사실은 CAGR 6.7%를 기록하며 분석 기간 종료시에는 3,168억 달러에 달할 것으로 예측됩니다. 독립형 검사 시설 부문의 성장률은 분석 기간 동안 CAGR 8.1%로 추정됩니다.

미국 시장은 추정 1,021억 달러, 중국은 CAGR 11.0%로 성장 예측

미국의 병리학 연구소 시장은 2024년에 1,021억 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 2030년까지 1,177억 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 11.0%를 기록할 것으로 예상됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 3.6%와 6.8%로 예측됩니다. 유럽에서는 독일이 CAGR 4.7%로 성장할 것으로 예측됩니다.

세계의 병리학 연구소 시장 - 주요 동향과 촉진요인 정리

병리학은 현대 의료의 중추인가? 확대되는 진단 실험실의 역할

병리연구소는 현대 의료의 핵심으로 질병 진단, 예후 예측, 치료 계획에서 매우 중요한 역할을 담당하고 있습니다. 암, 당뇨병, 심혈관질환 등 만성질환의 부담이 증가함에 따라 정확하고 신속한 진단에 대한 수요가 급증하고 있습니다. 병리 검사실은 질병 병리에 대한 중요한 인사이트를 제공하여 의사가 환자 치료에 대한 정보에 입각한 결정을 내릴 수 있도록 도와줍니다. 분자진단과 유전자 진단에 의존하는 정밀의료의 등장은 병리검사실의 중요성을 더욱 높이고 있습니다. 이들 연구소는 더 이상 일상적인 혈액 검사를 수행하는 센터가 아니라 디지털 병리학, AI 기반 진단 툴, 차세대 염기서열 분석(NGS) 등 첨단 기술을 통합하여 정확성과 효율성을 높이고 있습니다. COVID-19 팬데믹은 질병 감시 및 발병 관리에서 병리 실험실의 필수적인 역할을 부각시켰고, 진단 인프라에 대한 투자를 더욱 촉진했습니다. 전 세계 정부와 의료 서비스 제공자들은 고품질 진단 서비스에 대한 수요 증가에 대응하기 위해 검사실 확장, 인증, 자동화를 우선순위에 두고 있습니다. 질병의 조기 발견, 예방 의료, 맞춤형 치료 접근법이 점점 더 중요해지면서 병리 연구소는 고처리량 검사 및 고급 데이터 분석으로 전환기를 맞이하고 있습니다.

AI, 자동화, 디지털 진단, 기술이 병리학의 미래를 어떻게 바꿀 것인가?

인공지능(AI), 자동화, 디지털 병리 진단의 통합은 진단 검사실의 상황을 바꾸고 병리 진단 서비스를 보다 정확하고 효율적이며 확장 가능하게 만들고 있습니다. AI가 탑재된 영상 분석 도구는 생검 샘플의 해석을 강화하여 보다 신속하고 정확한 암 검출을 가능하게 합니다. 병리 슬라이드를 스캔하고 디지털화하는 디지털 병리학은 원격 진단, 원격 병리학, AI 기반 평가를 촉진하고, 시간을 단축하고, 지리적 장벽을 제거합니다. 실험실 자동화는 로봇을 통한 시료 처리, 고속 분석기, 클라우드 기반 데이터 관리 시스템을 통합하여 워크플로우를 간소화하고 인적 오류를 줄여 진단 처리량을 향상시키고 있습니다. 병리 검사에 머신러닝 알고리즘이 도입되면서 예측 분석이 강화되어 질병의 조기 발견과 위험도 평가가 가능해지고 있습니다. 중합효소 연쇄 반응(PCR)과 유전자 염기서열 분석 기술을 포함한 분자진단학의 발전은 병리검사실의 역량을 확장하고, 표적치료와 맞춤형 의료를 가능케 하고 있습니다. 혈액 샘플에서 암 바이오마커를 검출하는 액체 생검 기술은 기존의 생검을 대체할 수 있는 비침습적 방법을 제공함으로써 병리학 분야에서 획기적인 혁신으로 떠오르고 있습니다. 병리 검사실이 완전 자동화된 AI 지원 진단 모델로 전환함에 따라 병리 검사의 미래는 보다 데이터 중심적이고, 정확도가 높으며, 환자 중심이 될 준비가 되어 있습니다.

병리 검사 시장의 주요 플레이어는? 분야를 넘어선 접근성 확대

병리검사실 시장은 병원, 독립 진단 체인, 학술 연구기관, 정부 보건기관 등 각 분야에서 괄목할만한 성장을 보이고 있습니다. 병원을 기반으로 한 병리검사실은 임상 및 외과 부서를 지원하기 위해 병원 내 진단 서비스를 제공하기 때문에 여전히 지배적입니다. 퀘스트 진단(Quest Diagnostics), 랩코프(LabCorp), 유로핀스(Eurofins) 등의 독립 진단 체인은 인수 및 제휴를 통해 거점을 확장하고 다양한 전문 검사를 제공하고 있습니다. 재택 진단 서비스의 중요성이 높아짐에 따라 환자가 온라인으로 검사를 주문하고 디지털로 결과를 받아볼 수 있게 됨에 따라 소비자에게 직접 병리 검사에 대한 수요가 증가하고 있습니다. 정밀의료의 임상시험, 바이오마커 발굴, 중개연구를 지원하기 위해 학계와 연구기관은 병리실험실에 대한 투자를 늘리고 있습니다. 각국 정부는 농촌이나 의료 서비스가 부족한 지역에서 진단에 대한 접근성을 개선하기 위해 공공 병리 서비스를 확대하고 있습니다. 암, 감염성 질환, 유전성 질환의 유병률 증가로 조직병리학, 세포병리학, 분자진단학 등 전문 병리학 서비스에 대한 수요가 증가하고 있습니다. 또한, 병리검사실이 디지털 헬스 에코시스템 및 전자의무기록(EMR)과 통합되면서 헬스케어 네트워크 전반의 진단 접근성 및 데이터 공유가 강화되고 있습니다.

병리학 연구소 시장의 성장은 몇 가지 요인에 의해 초래됩니다. ..

만성질환, 특히 암, 심혈관질환, 감염성 질환의 유병률 증가는 병리 검사 시장의 주요 촉진요인입니다. AI를 탑재한 진단 툴과 디지털 병리 솔루션의 빠른 도입은 진단 정확도를 높이고 인적 오류를 줄이며 시장 확대에 박차를 가하고 있습니다. 맞춤형 의료와 정밀 진단에 대한 수요 증가는 분자 병리학 및 유전자 검사 서비스에 대한 투자를 촉진하고 있습니다. 원격의료와 원격 진단 기능의 부상으로 특히 지방이나 소외된 지역의 병리학 서비스에 대한 접근성이 향상되고 있습니다. 헬스케어 인프라 강화와 진단 정확도 향상을 위한 정부의 노력은 전 세계 병리학 연구소의 확장을 뒷받침하고 있습니다. 민간 진단 체인의 침투와 독립 검사기관의 통합은 규모의 경제를 가져와 진단 서비스를 보다 저렴하고 효율적으로 만들고 있습니다. 재택검사와 소비자 직접 검사 서비스에 대한 수요가 급증하면서 소비자에게 편의성과 빠른 검사 결과를 제공하며 병리 시장을 재편하고 있습니다. 질병의 조기 발견, 예방 건강관리, 정기적인 검진 프로그램에 대한 중요성이 강조되면서 병리검사 서비스의 도입이 더욱 활발해지고 있습니다. 의료 서비스 제공자, 제약사, 진단 연구소 간의 전략적 제휴는 새로운 바이오마커 및 진단 테스트 개발을 촉진하고 있습니다. 의료 시스템의 현대화가 진행됨에 따라 병리 검사 시장은 강력한 성장세를 보이고 있으며, 진단학은 보다 기술 중심적이고 환자 중심의 영역으로 변모하고 있습니다.

부문

유형(병원 실험실, 독립형 실험실, 진단 체인), 검사 서비스(일반 생리· 임상 검사, 영상·방사선 검사, 에소테릭 검사, COVID-19 검사), 최종사용(의사 소개 최종사용, 워크인 최종사용, 기업 최종사용)

조사 대상 기업 사례

  • Applied BioCode
  • BioReference Laboratories
  • Centro de Diagnosticos Brasil
  • Dr. Lal PathLabs
  • Eurofins Scientific
  • Exact Sciences Laboratories LLC
  • Falco Holdings Co., Ltd.
  • Healius Limited
  • KingMed Diagnostics
  • Laboratory Corporation of America Holdings(Labcorp)
  • Metropolis Healthcare
  • Nordic Bioscience
  • PathGroup
  • Quest Diagnostics Incorporated
  • Roche Diagnostics
  • Siemens Healthineers
  • Sonic Healthcare Limited
  • Spectra Laboratories
  • SYNLAB International GmbH
  • Unilabs

AI 통합

Global Industry Analysts는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 일반적인 LLM 및 업계별 SLM 쿼리를 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

ksm 25.08.08

Global Pathology Laboratories Market to Reach US$564.8 Billion by 2030

The global market for Pathology Laboratories estimated at US$374.7 Billion in the year 2024, is expected to reach US$564.8 Billion by 2030, growing at a CAGR of 7.1% over the analysis period 2024-2030. Hospital-based Laboratories, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$316.8 Billion by the end of the analysis period. Growth in the Standalone Labs segment is estimated at 8.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$102.1 Billion While China is Forecast to Grow at 11.0% CAGR

The Pathology Laboratories market in the U.S. is estimated at US$102.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$117.7 Billion by the year 2030 trailing a CAGR of 11.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.6% and 6.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.7% CAGR.

Global Pathology Laboratories Market - Key Trends & Drivers Summarized

Is Pathology the Backbone of Modern Healthcare? The Expanding Role of Diagnostic Laboratories

Pathology laboratories serve as the cornerstone of modern healthcare, playing a pivotal role in disease diagnosis, prognosis, and treatment planning. With the increasing burden of chronic diseases such as cancer, diabetes, and cardiovascular disorders, the demand for accurate and timely diagnostics has surged. Pathology labs provide critical insights into disease pathology, allowing physicians to make informed decisions about patient care. The advent of precision medicine, which relies on molecular and genetic diagnostics, has further propelled the significance of pathology laboratories. These labs are no longer just centers for routine blood work; they now integrate sophisticated technologies such as digital pathology, AI-powered diagnostic tools, and next-generation sequencing (NGS) to enhance accuracy and efficiency. The COVID-19 pandemic highlighted the indispensable role of pathology labs in disease surveillance and outbreak management, further driving investment in diagnostic infrastructure. Governments and healthcare providers worldwide are prioritizing laboratory expansion, accreditation, and automation to meet the rising demand for high-quality diagnostic services. With an increasing emphasis on early disease detection, preventive healthcare, and personalized treatment approaches, pathology laboratories are undergoing a transformative shift towards high-throughput testing and advanced data analytics.

How Is Technology Reshaping the Future of Pathology? AI, Automation & Digital Diagnostics

The integration of artificial intelligence (AI), automation, and digital pathology is revolutionizing the landscape of diagnostic laboratories, making pathology services more accurate, efficient, and scalable. AI-powered image analysis tools are enhancing the interpretation of biopsy samples, enabling faster and more precise cancer detection. Digital pathology, which involves the scanning and digitization of pathology slides, is facilitating remote diagnostics, telepathology, and AI-driven assessments, reducing turnaround times and eliminating geographical barriers. Laboratory automation is streamlining workflows by integrating robotic sample processing, high-speed analyzers, and cloud-based data management systems, reducing human error and improving diagnostic throughput. The implementation of machine learning algorithms in pathology is enhancing predictive analytics, allowing for earlier disease detection and risk assessment. Advances in molecular diagnostics, including polymerase chain reaction (PCR) and gene sequencing technologies, are expanding the capabilities of pathology labs, enabling targeted therapies and personalized medicine. Liquid biopsy technology, which detects cancer biomarkers from blood samples, is emerging as a groundbreaking innovation in pathology, offering a non-invasive alternative to traditional biopsies. As pathology labs move towards fully automated, AI-assisted diagnostic models, the future of pathology is poised to be more data-driven, precise, and patient-centric.

Who Are the Key Players in the Pathology Market? Expanding Accessibility Across Sectors

The pathology laboratory market is witnessing significant expansion across hospitals, independent diagnostic chains, academic research institutions, and government health agencies. Hospital-based pathology labs remain dominant, as they provide in-house diagnostic services to support clinical and surgical departments. Independent diagnostic chains, such as Quest Diagnostics, LabCorp, and Eurofins, are expanding their footprint through acquisitions and partnerships, offering a wide array of specialized tests. The growing prominence of at-home diagnostic services is fueling the demand for direct-to-consumer pathology testing, where patients can order tests online and receive results digitally. Academic and research institutions are increasingly investing in pathology labs to support clinical trials, biomarker discovery, and translational research in precision medicine. Governments across various countries are expanding public pathology services to improve access to diagnostics in rural and underserved areas. The demand for specialized pathology services, such as histopathology, cytopathology, and molecular diagnostics, is rising, driven by the increasing prevalence of cancer, infectious diseases, and genetic disorders. Additionally, the integration of pathology labs with digital health ecosystems and electronic medical records (EMRs) is enhancing diagnostic accessibility and data sharing across healthcare networks.

The Growth in the Pathology Laboratories Market Is Driven by Several Factors…

The increasing prevalence of chronic diseases, particularly cancer, cardiovascular diseases, and infectious diseases, is a major driver of the pathology laboratory market. The rapid adoption of AI-powered diagnostic tools and digital pathology solutions is enhancing diagnostic accuracy and reducing human error, fueling market expansion. The growing demand for personalized medicine and precision diagnostics is driving investment in molecular pathology and genetic testing services. The rise of telemedicine and remote diagnostic capabilities is increasing accessibility to pathology services, particularly in rural and underserved regions. Government initiatives aimed at strengthening healthcare infrastructure and improving diagnostic accuracy are supporting the expansion of pathology laboratories worldwide. The increasing penetration of private diagnostic chains and the consolidation of independent laboratories are leading to economies of scale, making diagnostic services more affordable and efficient. The surge in demand for at-home and direct-to-consumer testing services is reshaping the pathology market, offering convenience and rapid test results to consumers. The growing emphasis on early disease detection, preventive healthcare, and routine screening programs is further driving the adoption of pathology services. Strategic collaborations between healthcare providers, pharmaceutical companies, and diagnostic labs are fostering the development of novel biomarkers and diagnostic tests. As healthcare systems continue to modernize, the pathology laboratory market is set for robust growth, transforming diagnostics into a more technology-driven and patient-focused domain.

SCOPE OF STUDY:

The report analyzes the Pathology Laboratories market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Hospital-based Laboratories, Standalone Labs, Diagnostic Chains); Testing Service (General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests, COVID-19 Tests); End-Use (Physician Referrals End-Use, Walk-ins End-Use, Corporate End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

  • Applied BioCode
  • BioReference Laboratories
  • Centro de Diagnosticos Brasil
  • Dr. Lal PathLabs
  • Eurofins Scientific
  • Exact Sciences Laboratories LLC
  • Falco Holdings Co., Ltd.
  • Healius Limited
  • KingMed Diagnostics
  • Laboratory Corporation of America Holdings (Labcorp)
  • Metropolis Healthcare
  • Nordic Bioscience
  • PathGroup
  • Quest Diagnostics Incorporated
  • Roche Diagnostics
  • Siemens Healthineers
  • Sonic Healthcare Limited
  • Spectra Laboratories
  • SYNLAB International GmbH
  • Unilabs

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Pathology Laboratories - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Chronic and Infectious Diseases Spurs Demand for Advanced Pathology Services
    • Growing Global Focus on Early Diagnosis and Preventive Care Drives Laboratory Test Volumes
    • Technological Innovation in Digital Pathology and AI-Based Image Analysis Strengthens Market Transformation
    • Increased Demand for Personalized and Precision Medicine Expands Role of Molecular Pathology Labs
    • Accelerated Adoption of Automation and Sample Throughput Optimization in Labs
    • Rising Healthcare Expenditure in Emerging Markets Propels Investment in Modern Pathology Infrastructure
    • Integration with Hospital Information Systems Enhances Workflow Efficiency and Diagnostic Turnaround
    • Laboratory Consolidation Trends Support Centralized and Scalable Testing Models
    • Surge in Cancer Screening Programs Globally Throws Spotlight on Histopathology and Cytopathology
    • Partnerships Between Diagnostics Providers and Pharma Companies Boost Companion Diagnostics Services
    • Outsourcing of Pathology Services by Hospitals Expands Market for Independent Laboratories
    • Advancements in Tissue Processing and Staining Technologies Improve Accuracy and Speed of Analysis
    • Growing Demand for Liquid Biopsy and Genomic Testing Creates New Revenue Streams for Pathology Labs
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Pathology Laboratories Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Pathology Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Pathology Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Pathology Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Hospital-based Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Hospital-based Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Hospital-based Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Standalone Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Standalone Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Standalone Labs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Diagnostic Chains by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Diagnostic Chains by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Diagnostic Chains by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Corporate End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Corporate End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Corporate End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Physician Referrals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Physician Referrals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Physician Referrals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Walk-ins End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Walk-ins End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Walk-ins End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for General Physiological & Clinical Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for General Physiological & Clinical Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for General Physiological & Clinical Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Imaging & Radiology Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Imaging & Radiology Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Imaging & Radiology Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Esoteric Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Esoteric Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Esoteric Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for COVID-19 Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for COVID-19 Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for COVID-19 Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Pathology Laboratories Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Pathology Laboratories by Type - Percentage Breakdown of Value Sales for Hospital-based Laboratories, Standalone Labs and Diagnostic Chains for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Pathology Laboratories by End-Use - Percentage Breakdown of Value Sales for Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Pathology Laboratories by Testing Service - Percentage Breakdown of Value Sales for General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Pathology Laboratories by Type - Percentage Breakdown of Value Sales for Hospital-based Laboratories, Standalone Labs and Diagnostic Chains for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Pathology Laboratories by End-Use - Percentage Breakdown of Value Sales for Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Pathology Laboratories by Testing Service - Percentage Breakdown of Value Sales for General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests for the Years 2015, 2025 & 2030
  • JAPAN
    • Pathology Laboratories Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Pathology Laboratories by Type - Percentage Breakdown of Value Sales for Hospital-based Laboratories, Standalone Labs and Diagnostic Chains for the Years 2015, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Pathology Laboratories by End-Use - Percentage Breakdown of Value Sales for Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use for the Years 2015, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Pathology Laboratories by Testing Service - Percentage Breakdown of Value Sales for General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests for the Years 2015, 2025 & 2030
  • CHINA
    • Pathology Laboratories Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 62: China Recent Past, Current & Future Analysis for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Pathology Laboratories by Type - Percentage Breakdown of Value Sales for Hospital-based Laboratories, Standalone Labs and Diagnostic Chains for the Years 2015, 2025 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Pathology Laboratories by End-Use - Percentage Breakdown of Value Sales for Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Pathology Laboratories by Testing Service - Percentage Breakdown of Value Sales for General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests for the Years 2015, 2025 & 2030
  • EUROPE
    • Pathology Laboratories Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Pathology Laboratories by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Pathology Laboratories by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Pathology Laboratories by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Pathology Laboratories by Type - Percentage Breakdown of Value Sales for Hospital-based Laboratories, Standalone Labs and Diagnostic Chains for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Pathology Laboratories by End-Use - Percentage Breakdown of Value Sales for Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use for the Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Pathology Laboratories by Testing Service - Percentage Breakdown of Value Sales for General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests for the Years 2015, 2025 & 2030
  • FRANCE
    • Pathology Laboratories Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 83: France Recent Past, Current & Future Analysis for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Pathology Laboratories by Type - Percentage Breakdown of Value Sales for Hospital-based Laboratories, Standalone Labs and Diagnostic Chains for the Years 2015, 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Pathology Laboratories by End-Use - Percentage Breakdown of Value Sales for Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use for the Years 2015, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Pathology Laboratories by Testing Service - Percentage Breakdown of Value Sales for General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests for the Years 2015, 2025 & 2030
  • GERMANY
    • Pathology Laboratories Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Pathology Laboratories by Type - Percentage Breakdown of Value Sales for Hospital-based Laboratories, Standalone Labs and Diagnostic Chains for the Years 2015, 2025 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Pathology Laboratories by End-Use - Percentage Breakdown of Value Sales for Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use for the Years 2015, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Pathology Laboratories by Testing Service - Percentage Breakdown of Value Sales for General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Pathology Laboratories by Type - Percentage Breakdown of Value Sales for Hospital-based Laboratories, Standalone Labs and Diagnostic Chains for the Years 2015, 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Pathology Laboratories by End-Use - Percentage Breakdown of Value Sales for Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use for the Years 2015, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Pathology Laboratories by Testing Service - Percentage Breakdown of Value Sales for General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Pathology Laboratories Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 110: UK Recent Past, Current & Future Analysis for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Pathology Laboratories by Type - Percentage Breakdown of Value Sales for Hospital-based Laboratories, Standalone Labs and Diagnostic Chains for the Years 2015, 2025 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Pathology Laboratories by End-Use - Percentage Breakdown of Value Sales for Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use for the Years 2015, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Pathology Laboratories by Testing Service - Percentage Breakdown of Value Sales for General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Spain 15-Year Perspective for Pathology Laboratories by Type - Percentage Breakdown of Value Sales for Hospital-based Laboratories, Standalone Labs and Diagnostic Chains for the Years 2015, 2025 & 2030
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Spain 15-Year Perspective for Pathology Laboratories by End-Use - Percentage Breakdown of Value Sales for Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use for the Years 2015, 2025 & 2030
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Spain 15-Year Perspective for Pathology Laboratories by Testing Service - Percentage Breakdown of Value Sales for General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Russia 15-Year Perspective for Pathology Laboratories by Type - Percentage Breakdown of Value Sales for Hospital-based Laboratories, Standalone Labs and Diagnostic Chains for the Years 2015, 2025 & 2030
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Russia 15-Year Perspective for Pathology Laboratories by End-Use - Percentage Breakdown of Value Sales for Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use for the Years 2015, 2025 & 2030
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Russia 15-Year Perspective for Pathology Laboratories by Testing Service - Percentage Breakdown of Value Sales for General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Pathology Laboratories by Type - Percentage Breakdown of Value Sales for Hospital-based Laboratories, Standalone Labs and Diagnostic Chains for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for Pathology Laboratories by End-Use - Percentage Breakdown of Value Sales for Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 15-Year Perspective for Pathology Laboratories by Testing Service - Percentage Breakdown of Value Sales for General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Pathology Laboratories Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Pathology Laboratories by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Pathology Laboratories by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Pathology Laboratories by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Pathology Laboratories by Type - Percentage Breakdown of Value Sales for Hospital-based Laboratories, Standalone Labs and Diagnostic Chains for the Years 2015, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Pathology Laboratories by End-Use - Percentage Breakdown of Value Sales for Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use for the Years 2015, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 15-Year Perspective for Pathology Laboratories by Testing Service - Percentage Breakdown of Value Sales for General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Pathology Laboratories Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Australia 15-Year Perspective for Pathology Laboratories by Type - Percentage Breakdown of Value Sales for Hospital-based Laboratories, Standalone Labs and Diagnostic Chains for the Years 2015, 2025 & 2030
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Australia 15-Year Perspective for Pathology Laboratories by End-Use - Percentage Breakdown of Value Sales for Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use for the Years 2015, 2025 & 2030
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Australia 15-Year Perspective for Pathology Laboratories by Testing Service - Percentage Breakdown of Value Sales for General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests for the Years 2015, 2025 & 2030
  • INDIA
    • Pathology Laboratories Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 167: India Recent Past, Current & Future Analysis for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: India 15-Year Perspective for Pathology Laboratories by Type - Percentage Breakdown of Value Sales for Hospital-based Laboratories, Standalone Labs and Diagnostic Chains for the Years 2015, 2025 & 2030
    • TABLE 170: India Recent Past, Current & Future Analysis for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: India 15-Year Perspective for Pathology Laboratories by End-Use - Percentage Breakdown of Value Sales for Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use for the Years 2015, 2025 & 2030
    • TABLE 173: India Recent Past, Current & Future Analysis for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: India 15-Year Perspective for Pathology Laboratories by Testing Service - Percentage Breakdown of Value Sales for General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: South Korea 15-Year Perspective for Pathology Laboratories by Type - Percentage Breakdown of Value Sales for Hospital-based Laboratories, Standalone Labs and Diagnostic Chains for the Years 2015, 2025 & 2030
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: South Korea 15-Year Perspective for Pathology Laboratories by End-Use - Percentage Breakdown of Value Sales for Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use for the Years 2015, 2025 & 2030
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: South Korea 15-Year Perspective for Pathology Laboratories by Testing Service - Percentage Breakdown of Value Sales for General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Pathology Laboratories by Type - Percentage Breakdown of Value Sales for Hospital-based Laboratories, Standalone Labs and Diagnostic Chains for the Years 2015, 2025 & 2030
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Pathology Laboratories by End-Use - Percentage Breakdown of Value Sales for Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use for the Years 2015, 2025 & 2030
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Pathology Laboratories by Testing Service - Percentage Breakdown of Value Sales for General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Pathology Laboratories Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Pathology Laboratories by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Pathology Laboratories by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Pathology Laboratories by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Pathology Laboratories by Type - Percentage Breakdown of Value Sales for Hospital-based Laboratories, Standalone Labs and Diagnostic Chains for the Years 2015, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Pathology Laboratories by End-Use - Percentage Breakdown of Value Sales for Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use for the Years 2015, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Latin America 15-Year Perspective for Pathology Laboratories by Testing Service - Percentage Breakdown of Value Sales for General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Argentina 15-Year Perspective for Pathology Laboratories by Type - Percentage Breakdown of Value Sales for Hospital-based Laboratories, Standalone Labs and Diagnostic Chains for the Years 2015, 2025 & 2030
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Argentina 15-Year Perspective for Pathology Laboratories by End-Use - Percentage Breakdown of Value Sales for Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use for the Years 2015, 2025 & 2030
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Argentina 15-Year Perspective for Pathology Laboratories by Testing Service - Percentage Breakdown of Value Sales for General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Brazil 15-Year Perspective for Pathology Laboratories by Type - Percentage Breakdown of Value Sales for Hospital-based Laboratories, Standalone Labs and Diagnostic Chains for the Years 2015, 2025 & 2030
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Brazil 15-Year Perspective for Pathology Laboratories by End-Use - Percentage Breakdown of Value Sales for Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use for the Years 2015, 2025 & 2030
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: Brazil 15-Year Perspective for Pathology Laboratories by Testing Service - Percentage Breakdown of Value Sales for General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Mexico 15-Year Perspective for Pathology Laboratories by Type - Percentage Breakdown of Value Sales for Hospital-based Laboratories, Standalone Labs and Diagnostic Chains for the Years 2015, 2025 & 2030
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: Mexico 15-Year Perspective for Pathology Laboratories by End-Use - Percentage Breakdown of Value Sales for Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use for the Years 2015, 2025 & 2030
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: Mexico 15-Year Perspective for Pathology Laboratories by Testing Service - Percentage Breakdown of Value Sales for General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 15-Year Perspective for Pathology Laboratories by Type - Percentage Breakdown of Value Sales for Hospital-based Laboratories, Standalone Labs and Diagnostic Chains for the Years 2015, 2025 & 2030
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 15-Year Perspective for Pathology Laboratories by End-Use - Percentage Breakdown of Value Sales for Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use for the Years 2015, 2025 & 2030
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 15-Year Perspective for Pathology Laboratories by Testing Service - Percentage Breakdown of Value Sales for General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Pathology Laboratories Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Pathology Laboratories by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Pathology Laboratories by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Pathology Laboratories by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Pathology Laboratories by Type - Percentage Breakdown of Value Sales for Hospital-based Laboratories, Standalone Labs and Diagnostic Chains for the Years 2015, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Pathology Laboratories by End-Use - Percentage Breakdown of Value Sales for Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use for the Years 2015, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 253: Middle East 15-Year Perspective for Pathology Laboratories by Testing Service - Percentage Breakdown of Value Sales for General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 256: Iran 15-Year Perspective for Pathology Laboratories by Type - Percentage Breakdown of Value Sales for Hospital-based Laboratories, Standalone Labs and Diagnostic Chains for the Years 2015, 2025 & 2030
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 259: Iran 15-Year Perspective for Pathology Laboratories by End-Use - Percentage Breakdown of Value Sales for Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use for the Years 2015, 2025 & 2030
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 262: Iran 15-Year Perspective for Pathology Laboratories by Testing Service - Percentage Breakdown of Value Sales for General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 265: Israel 15-Year Perspective for Pathology Laboratories by Type - Percentage Breakdown of Value Sales for Hospital-based Laboratories, Standalone Labs and Diagnostic Chains for the Years 2015, 2025 & 2030
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 268: Israel 15-Year Perspective for Pathology Laboratories by End-Use - Percentage Breakdown of Value Sales for Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use for the Years 2015, 2025 & 2030
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 271: Israel 15-Year Perspective for Pathology Laboratories by Testing Service - Percentage Breakdown of Value Sales for General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 15-Year Perspective for Pathology Laboratories by Type - Percentage Breakdown of Value Sales for Hospital-based Laboratories, Standalone Labs and Diagnostic Chains for the Years 2015, 2025 & 2030
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 15-Year Perspective for Pathology Laboratories by End-Use - Percentage Breakdown of Value Sales for Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use for the Years 2015, 2025 & 2030
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 15-Year Perspective for Pathology Laboratories by Testing Service - Percentage Breakdown of Value Sales for General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 283: UAE 15-Year Perspective for Pathology Laboratories by Type - Percentage Breakdown of Value Sales for Hospital-based Laboratories, Standalone Labs and Diagnostic Chains for the Years 2015, 2025 & 2030
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 286: UAE 15-Year Perspective for Pathology Laboratories by End-Use - Percentage Breakdown of Value Sales for Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use for the Years 2015, 2025 & 2030
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 289: UAE 15-Year Perspective for Pathology Laboratories by Testing Service - Percentage Breakdown of Value Sales for General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 15-Year Perspective for Pathology Laboratories by Type - Percentage Breakdown of Value Sales for Hospital-based Laboratories, Standalone Labs and Diagnostic Chains for the Years 2015, 2025 & 2030
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 15-Year Perspective for Pathology Laboratories by End-Use - Percentage Breakdown of Value Sales for Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use for the Years 2015, 2025 & 2030
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 15-Year Perspective for Pathology Laboratories by Testing Service - Percentage Breakdown of Value Sales for General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests for the Years 2015, 2025 & 2030
  • AFRICA
    • Pathology Laboratories Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Pathology Laboratories by Type - Hospital-based Laboratories, Standalone Labs and Diagnostic Chains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 301: Africa 15-Year Perspective for Pathology Laboratories by Type - Percentage Breakdown of Value Sales for Hospital-based Laboratories, Standalone Labs and Diagnostic Chains for the Years 2015, 2025 & 2030
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Pathology Laboratories by End-Use - Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 304: Africa 15-Year Perspective for Pathology Laboratories by End-Use - Percentage Breakdown of Value Sales for Corporate End-Use, Physician Referrals End-Use and Walk-ins End-Use for the Years 2015, 2025 & 2030
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Pathology Laboratories by Testing Service - General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 307: Africa 15-Year Perspective for Pathology Laboratories by Testing Service - Percentage Breakdown of Value Sales for General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests and COVID-19 Tests for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제